Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-020527

EVP of Research sold 130,000 shares at $29.75 ($3,867,500)

  • EVP of Research acquired 95,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Huizinga Robert Bindert · EVP of Research

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-25 Exercise or conversion : show line 1 in the form +95,000 $3.20 $304,000 195,728 D
2021-10-25 Sale : show line 2 in the form −130,000 $29.75 $3,867,500 65,728 D
Open-market sales · 130,000 sh · avg $29.75 · $3,867,500

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-10-25 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −95,000 3,864 D
Loading xslF345X03/wf-form4_163528039067523.xml…